Sentences with phrase «dollar state program»

According to a new analysis by Empire Center health policy director Bill Hammond, a $ 1.1 billion - dollar state program to reimburse hospital charity care is shortchanging hospitals that serve poorer patient to the benefit of those that serve more affluent populations.

Not exact matches

The United States could lose up to 700,000 jobs and suffer billions of dollars in lost economic output if President Donald Trump ends a program granting work permits to the children of undocumented immigrants, a new report finds.
«This calculated theft reportedly netted Otto employees over half a billion dollars and allowed Uber to revive a stalled program, all at Waymo's expense,» the lawsuit states.
Over the past 30 years, policymakers from around the United States have spent countless hours and numerous dollars on programs, policies, and incentives to create venture - capital clusters and to stimulate investments in their cities and regions.
Robotics labs today are filled with million - dollar, state - of - the - art robots that struggle with mundane chores, such as gripping a cup of coffee or opening a door, even after months of programming.
Adding to the pressure on Dollar General were cuts in food - stamp programs as seven states, all governed by Republicans, ended benefits earlier than they had to.
Apple also boosted its capital return program by $ 100 billion, with repurchases from the increase set to begin in the June quarter, and said it bought $ 23.5 billion of stock back in the March quarter, a sign that it is bringing back most of its hundreds of billions of dollars in cash to the United States.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Revenue from California's Mental Health Services Act has funded billions of dollars in mental health programs across the state, but finding out what's available — and to whom — could be a challenge for consumers.
When a board of directors authorizes a share repurchase program, it typically states either the number of shares the company is interested in buying back or a dollar amount it will spend on its stock buyback.
But as cities, counties and states compete for economic development, spending on such programs nationwide has climbed into the billions of dollars, even in an era of fiscal austerity.
A robot can never work with an individual to translate someone's stated needs and wants into a dollar amount that will accomplish that financial plan and create such a program to get there.
At the federal level, the Department of Education can implement STEM as a requirement in America's classrooms, and fund more initiatives like Race to the Top, a $ 4 billion dollar program that to incentivizes states to develop next - generation educational standards.
All welfare - type programs are administered by the States today (social security being the exception) and are funded with a mix of State and Federal dollars.
I understand with arresting the pedophile Sandusky, the man should be castrated, but to fire a man who made Penn State relevant and gave the university its prestige, not forgetting the millions of dollars made through the football program, is absurd.
While I agree that we need separation of church and state... It is a stretch to say that our politicians are establishing a theocracy... on the other hand, you are turning a bling eye to the billions of dollars that have gone into hospitals, universities, feed the hunger programs... All funded by people of faith.
Overseen by the Division of Family and Children of the state's Family and Social Services Administration, FaithWorks provides assistance to faith - based organizations in applying for state and federal grant dollars to support new or existing programs geared to helping people attain self - sufficiency.
The fact that poverty remains a serious problem in the United States after the federal government has spent $ 22 trillion dollars on social welfare programs over the past fifty years should have taught us all something about the complex problems of empowering the poor.
Under the California provisions, for example, the state supreme court invalidated a program providing fourteen dollars» worth of purely secular books for the use of children enrolled in religious schools.
According to one estimate, only 6 percent of public early - childhood education and child - care dollars in the United States go to programs for children who have not yet reached their third birthday.
No state or federal child safety - net program allocates dollars specifically for the purchase of diapers.
Though there is a nearly two - year - old state mandate that opens the free summer lunch program to all children in Illinois — whether or not they're in summer school — there has not been much improvement in participation, and officials say millions of federal dollars available for the meals are going untapped.
Last week, an additional million - dollar grant was awarded to Mass Audubon, in partnership with the state Department of Conservation and Recreation, from the U.S. Fish and Wildlife Service's National Coastal Wetlands Conservation Program.
Although programs have proliferated to address the needs of fathers and families, there is also a need to evaluate their effectiveness in helping fathers become better parents and better partners.8 Federal and state policy makers have placed increasing demands on programs to evaluate the effects these programs have on fathers and families and whether they are worth investing public dollars.9
The Partners have successfully worked in 7 states, granting over 2 million dollars to over 20 school districts to expand breakfast in the classroom programs in almost 100 schools.
At 3:15 p.m., Sen. Jose Peralta, Assemblywoman Deborah Glick, NYC DOT Commissioner Polly Trottenberg and advocates discuss legislation aimed at expanding the speed camera program in school zones in New York City, Million Dollar Staircase, 3rd Floor, state Capitol, Albany.
One could also attach a special surcharge to copyright enforcement actions in federal court - many state courts finance a variety of low dollar programs that way.
At issue were comments O'Luck made on the Times» City Room blog in February 2009, in which he said that if government programs that benefit businesses owned by women and minorities weren't around «white men and the connected would have access to nearly 100 % of all city, state, and federal government dollars spent.»
Assemblyman renews call for creation of a CHIPS - like state program for towns & cities to protect water, sewer, storm water infrastructure & save tax dollars
Previous ads cite Faso's record of results as an innovative leader, notably his efforts to enact balanced state budgets, push for a property tax cap and his role in creating New York's STAR program, which saves taxpayers millions of dollars each year.
SYRACUSE, N.Y. - New York state shut down its out - of - control Empire Zone business incentive program in 2010 after providing millions of dollars to companies that state officials never intended to help.
Assemblyman Jim Tedisco (R,C,I - Glenville) today says two water main breaks in Rotterdam and a sewer break in Amsterdam underscore the continued urgent need for a new state program to repair and maintain vital local drinking water, sewer, storm water management and gas line infrastructure to protect lives, secure the viability of roads and bridges aboveground, and save tax dollars.
Governor Cuomo released a state budget plan that closes a $ 2 billion dollar gap, recommends a phased in state takeover of county health care costs, and offers an ultimatum to schools to accept a teacher evaluation program or lose access to increased school funding.
Trump on Wednesday blasted the tens of millions in taxpayer dollars that New York state has spent on the governor's Start Up NY Jobs program.
Governor Cuomo released a state budget plan that closes a $ 2 billion dollar gap, recommends a phased in state takeover of county health care costs, and offers an ultimatum to schools to accept a teacher evaluation program or lose increased school funding.
New York's multi-billion dollar Medicaid program is paid for by state, county and federal taxes.
Republicans in the State Assembly say they are frustrated that there's been no increased oversight in the state's billions of dollars in economic development contracts, including the governor's signature programs like the Buffalo BilState Assembly say they are frustrated that there's been no increased oversight in the state's billions of dollars in economic development contracts, including the governor's signature programs like the Buffalo Bilstate's billions of dollars in economic development contracts, including the governor's signature programs like the Buffalo Billion.
The Cuomo administration says the program actually saves money for the state by leveraging federal aid for certain noncitizens whose care is now fully paid for with state dollars.
Many schools plan to add new student programs and services next year, aided by millions of dollars in fresh financial assistance from Albany, as well as reductions in state pension costs.
Kink says he does like the governors» job creation programs - the biggest one would use over one and half billion state dollars to leverage billions more in investments for road and bridge and other infrastructure repairs, including a new Tappan Zee Bridge, better flood control, and renewable energy systems.
Replicating the success of the CHIPS program on the state level to allow local governments to S.W.A.P. - out deteriorating drinking water, storm water, gas lines and sanitary sewer infrastructure makes sense because an ounce of prevention now can save tax dollars later and prevent costly breaks.»
And last week, the leader of Ontario vowed to push a law that could restrict New York companies from bidding on billions of dollars of government contracts in that Canadian province in retaliation for a «Buy American» program signed two months ago by Gov. Andrew Cuomo for major state road and bridge projects.
State and county leaders, meanwhile, have poured millions of dollars into social services and gang - intervention programs aimed at eliminating MS - 13's most important asset, its recruits.
Assemblyman Jim Tedisco (R,C,I - Glenville), Assemblyman Steve McLaughlin (R,C,I - Schaghticoke) and Assemblyman Phil Palmesano (R,C,I - Corning) are joining with several local Capital Region officials in seeking a new state program to repair and maintain vital local drinking water, sewer, storm water management and gas line infrastructure to protect lives, secure the viability of roads and bridges aboveground and save tax dollars.
In states like California, one of eight where recreational marijuana is legal, hundreds of millions of dollars in revenue have been raised for school construction and health programs.
The House passed a measure in a 230 - 188 vote that would reverse a last - minute rule from the Obama administration that said conservative states can't block the women's health and abortion provider from receiving family planning dollars under the Title X program.
The audit showed continued spending on advertising did not lead to an increase in the number of companies who applied for the program, and the state continued spending millions of dollars on advertising even as monthly applications dropped off from roughly 5,300 in January 2014 to about 500 in June of 2014.
«In 2006, the Erie County legislature passed what is called the New York State Certified Training Program, which is often known as the apprenticeship law... It ensures taxpayer dollars that are paying for construction jobs associated with Erie County government are going towards Erie County residents who are working on these projects.
But, Onondaga County Executive Joanie Mahoney says every single dollar Onondaga County receives from property taxes goes to the state, due to a series of programs for which counties are required to pay the state.
ALBANY — State comptroller Tom DiNapoli criticized the state's decision to spend hundreds of millions of dollars on advertising to promote Governor Andrew Cuomo's signature economic development programs, including the fledgling Start - Up NY, in an audit released on MoState comptroller Tom DiNapoli criticized the state's decision to spend hundreds of millions of dollars on advertising to promote Governor Andrew Cuomo's signature economic development programs, including the fledgling Start - Up NY, in an audit released on Mostate's decision to spend hundreds of millions of dollars on advertising to promote Governor Andrew Cuomo's signature economic development programs, including the fledgling Start - Up NY, in an audit released on Monday.
a b c d e f g h i j k l m n o p q r s t u v w x y z